Intraocular hemorrhage

Last updated
Intraocular hemorrhage
Schematic diagram of the human eye en.svg
Schematic diagram of the human eye
Specialty Ophthalmology   OOjs UI icon edit-ltr-progressive.svg

Intraocular hemorrhage (sometimes called hemophthalmos or hemophthalmia) is bleeding inside the eye (oculus in Latin). Bleeding can occur from any structure of the eye where there is vasculature or blood flow, including the anterior chamber, vitreous cavity, retina, choroid, suprachoroidal space, or optic disc. [1]

Contents

Intraocular hemorrhage may be caused by physical trauma (direct injury to the eye); ocular surgery (such as to repair cataracts); or other diseases, injuries, or disorders (such as diabetes, hypertension, or shaken baby syndrome). [2] Severe bleeding may cause high pressure inside the eye, leading to blindness.

Types

Intraocular hemorrhage is classified based on the location of the bleeding:

Another type of ocular hemorrhage is subconjunctival bleeding, which occurs just underneath the conjunctiva. [8]

Causes

A subconjunctival hemorrhage can often occur without any obvious cause or harm to the eye. A strong enough sneeze or cough can cause a blood vessel in the eye to burst.

Hyphema is a result of blunt or penetrating trauma to the orbit that increases intraocular pressure, causing tears in the vessels of the ciliary body and iris. Certain medical conditions—such as leukemia, hemophilia, Von Willebrand disease, and sickle cell disease—put patients at risk of developing hyphema, as does the use of anticoagulant medications. Neovascularization of the eye, often associated with diabetes mellitus, is also a risk factor. People who have undergone surgery (such as for cataracts) may develop hyphema during or up to a week after the surgery. [9]

Vitreous hemorrhage can be caused by proliferative diabetic retinopathy, vitreous detachment with or without retinal breaks, and trauma. Less common causes include vascular occlusive disease, retinal arterial macroaneurysm, hemoglobinopathy, age-related macular degeneration, and intraocular tumors. [10]

Subretinal hemorrhage is caused by retinal and/or choroidal circulation. Significant subretinal hemorrhage occurs in several conditions, but is most commonly associated with age-related macular degeneration, presumed ocular histoplasmosis, high myopia, retinal arterial macroaneurysm, and trauma. [11] Other causes include Terson syndrome (as a result of subarachnoid hemorrhage), hemophilia, anticoagulants, and thrombolysis.

Pathophysiology

Hemorrhages present differently depending on their type.

A subconjunctival hemorrhage appears as a bright red patch on the white (sclera) of the eye and is commonly referred to as a burst blood vessel.

In hyphema, blood pools in the anterior chamber, where the iris (the colored part of the eye) and the pupil are located. Hyphemas are graded based on the amount of blood covering the cornea. Once an open globe has been ruled out, intraocular pressure should be checked and treated if greater than 21 mm Hg. All patients with hyphema require ophthalmology consultation. Any patient with a hyphema larger than grade II, elevated intraocular pressure, or sickle cell disease—or who is unable to comply with daily ophthalmology evaluations—should be admitted to the hospital. [9]

A vitreous hemorrhage is bleeding into the vitreous gel: the thick, clear fluid in the center of the eye that allows light to pass through to the retina, the nerve fiber layer that sends images to the brain. [5]

A subretinal hemorrhage is an accumulation of blood between the photoreceptor layer and the retinal pigment epithelium (RPE), arising from the choroidal or retinal circulation. These hemorrhages are a deep red color and broad in shape, with diffuse margins. They are commonly seen in age-related macular degeneration, presumed ocular histoplasmosis, high myopia, polypoidal choroidal vasculopathy (PCV), retinal macroaneurysm, and trauma. [12]

Submacular hemorrhages are commonly seen in choroidal neovascular membranes secondary to age-related macular degeneration. They are an uncommon complication of choroidal or retinal vascular abnormalities, including PCV, choroidal neovascularization (CNV), and retinal macroaneurysm. [13]

Diagnosis

A subconjunctival hemorrhage is diagnosed by visual examination; it will present as a red splotch visible to the naked eye. No other testing is required.

Hyphema is diagnosed with a slit lamp examination. If the hyphema is large enough, it will also be visible on a penlight exam. Symptoms include bleeding in the front of the eye, sensitivity to light, pain in the eye, and blurry, clouded, or blocked vision. [14]

Vitreous hemorrhage may be diagnosed when symptoms such as floaters, haziness, perception of shadows, or cobwebs are present. It is usually painless. Visual acuity may be affected variably depending on the amount of blood in the visual axis. Diagnosis is made with slit lamp examination and confirmed with optical coherence tomography (OCT).

Subretinal hemorrhages are diagnosed with a slit lamp examination of the anterior segment, dilated fundus examination, and intraocular pressure measurement. OCT, fundus fluorescein angiography (FFA), and fundus photography are helpful to determine the location and depth of the hemorrhage. One should suspect abusive head trauma if a child younger than three shows retinal hemorrhages with an intracranial injury. [12]

Submacular hemorrhage patients often present with decreased central vision, sometimes 20/200 or worse. On a dilated fundus examination, submacular hemorrhage can be observed as an elevation of the retina, which can also be associated with a hemorrhagic detachment of the retinal pigment epithelium. [13]

Treatment

Subconjunctival hemorrhage requires no treatment and will resolve on its own within two weeks. [15]

Hyphema treatment begins with head elevation to about 30 degrees, including while sleeping. An eye shield should also be placed and worn until the hyphema has completely resolved. [9]

Vitreous hemorrhages are treated by targeting the underlying cause, such as with laser photo-coagulation for proliferative diabetic retinopathy or retinal detachment. Occasionally, a hemorrhage does not resolve on its own, and vitrectomy surgery—which removes the vitreous and replaces it with a saltwater solution similar to the eye’s natural fluids—becomes necessary. [10]

Subretinal hemorrhages do not always require immediate treatment. Those that do not obscure or threaten vision can be monitored to evaluate their progression in size and number, but the primary disorder behind the hemorrhages needs to be diagnosed and addressed. Direct intervention is indicated for hemorrhages with the potential to permanently damage vision. [12]

Treatment for submacular hemorrhages depends on the severity of the injury and pre-existing macular function. Damage to the retina can occur in as little as 24 hours. Overall, the window of opportunity for successful recovery is thought to be within the first two weeks of onset. [8]

Prognosis

Prognosis depends on the location of the bleed, the amount of bleeding, the rate of clearing of blood, whether the blood is affecting visual acuity, complications (such as corneal staining, retinal detachment, pre-retinal fibrosis, ischemic optic atrophy, or glaucoma), and the severity of involvement of the macular region.

Subconjunctival hemorrhage will resolve on its own within two weeks.

Hyphema has a relatively good prognosis. Most patients will fully recover, but complications are more likely in those with comorbidities such as sickle cell disease or other diseases that lead to an increase in the size of the hyphema. [9]

Vitreous hemorrhages normally require no treatment. The blood typically clears by itself and vision is restored, though this may take up to several months. In more severe cases, or if the hemorrhage does not clear up as expected, an eye doctor may perform a vitrectomy. [10]

Subretinal hemorrhage secondary to age-related macular degeneration (AMD) has a poor visual prognosis. Surgery to drain the blood will only improve visual acuity in some patients. [12]

Submacular hemorrhage patients with an otherwise healthy retinal pigment epithelium (RPE) and photoreceptors will recover the most visual function. The prognosis is often poor in cases of advanced AMD due to underlying RPE disease, even with successful clearing and removal of the hemorrhage. [16]

Epidemiology

Traumatic eye injury can cause intraocular hemorrhage in people of any age and gender. However, injuries tend to be more common in young males due to more outdoor activities and heavy work. They are also more common in children during the summer.

The incidence of traumatic hyphema is approximately 12 per 100,000. Males are three to five times more affected than females. [17]

The annual incidence of vitreous hemorrhage is 7 per 1,000,000. [18] In the Chinese population, it occurs at a much higher rate of 4.8 cases per 10,000 person-years. Incidence is greater with age (mainly 40 to 59 years), male gender, and use of anticoagulants. [19]

Subretinal hemorrhage in adults is most often seen after 40 years of age, when systemic disorders become more common. Retinal hemorrhages were seen in 30% of physically abused children, most under six months of age. Birth-related retinal hemorrhages are seen in 25% of newborns with normal delivery and 40–50% of newborns with instrumental deliveries. [12]

Submacular hemorrhage typically occurs in elderly patients with exudative age-related macular degeneration, macroaneurysms, or polypoidal choroidal vasculopathy, and in all populations in cases of trauma. [1]

Research

Research has shown a link between intraocular hemorrhages and medications including warfarin and new oral anticoagulants.

Eighty cases of intraocular hemorrhage (vitreous, choroidal, or retinal) were identified with warfarin in the World Health Organization's Vigibase database from 1968–2015. [20] There were a total of 156 cases with new oral anticoagulants (82 with rivaroxaban, 65 with dabigatran, and 9 with apixaban). Warfarin had the highest reports of suprachoroidal hemorrhage. Rivaroxaban and dabigatran had the highest reports of retinal and vitreous hemorrhage. Apixaban also had high reports of retinal and vitreous hemorrhage, but the number of cases reported was too small to make a meaningful impact. [20]

The incidence of intraocular hemorrhage is higher with warfarin and new oral anticoagulants than with other drugs in the World Health Organization's database. The high rate of choroidal hemorrhage associated with warfarin is likely due to the drug's long-term use. Rivaroxaban had a high number of reports of retinal and vitreous hemorrhage despite the fact that it was approved by the Food and Drug Administration a year later than dabigatran, suggesting a higher risk in patients taking rivaroxaban than patients taking dabigatran. Apixaban had the least association with either condition. This may be because it is the most recent of the drug class to be approved by the FDA (as of 2012). [20]

Research into hemorrhages in abused infants has found that infants with intracranial injuries usually present with abnormal central nervous system signs, intracranial hemorrhage, and intraocular hemorrhage. [21] Several studies have found that the reported incidence of child abuse is inaccurate due to a lack of complete and proper investigation of childhood fatalities, as well as poor reporting to state agencies. In one study, optic nerve sheath hemorrhage was present in all 13 infants with non-accidental intracranial injury, and multilayered retinal hemorrhage was present in at least one eye of 11 of the 13 infants. [21]

Hyphema is a complication that can occur after glaucoma filtering surgery, although the causes are not always well known. In some cases, abnormal vessels have been detected at the internal margin of the trabeculectomy opening, and they are assumed to be the cause of the hemorrhage. [22]

Related Research Articles

<span class="mw-page-title-main">Diabetic retinopathy</span> Medical condition

Diabetic retinopathy, is a medical condition in which damage occurs to the retina due to diabetes mellitus. It is a leading cause of blindness in developed countries.

<span class="mw-page-title-main">Vitrectomy</span> Surgery to remove vitreous humor from the eye

Vitrectomy is a surgery to remove some or all of the vitreous humor from the eye.

Retinal hemorrhage is a disorder of the eye in which bleeding occurs in the retina, the light sensitive tissue, located on the back wall of the eye. There are photoreceptor cells in the retina called rods and cones, which transduce light energy into nerve signals that can be processed by the brain to form visual images. Retinal hemorrhage is strongly associated with child abuse in infants and young children and often leaves such abused infants permanently blind. In older children and adults, retinal hemorrhage can be caused by several medical conditions such as hypertension, retinal vein occlusion, anemia, leukemia or diabetes.

<span class="mw-page-title-main">Retinal implant</span>

A retinal implant is a visual prosthesis for restoration of sight to patients blinded by retinal degeneration. The system is meant to partially restore useful vision to those who have lost their photoreceptors due to retinal diseases such as retinitis pigmentosa (RP) or age-related macular degeneration (AMD). Retinal implants are being developed by a number of private companies and research institutions, and three types are in clinical trials: epiretinal, subretinal, and suprachoroidal. The implants introduce visual information into the retina by electrically stimulating the surviving retinal neurons. So far, elicited percepts had rather low resolution, and may be suitable for light perception and recognition of simple objects.

Neovascularization is the natural formation of new blood vessels, usually in the form of functional microvascular networks, capable of perfusion by red blood cells, that form to serve as collateral circulation in response to local poor perfusion or ischemia.

<span class="mw-page-title-main">Intravitreal administration</span>

Intravitreal is a route of administration of a drug, or other substance, in which the substance is delivered into the vitreous humor of the eye. "Intravitreal" literally means "inside an eye". Intravitreal injections were first introduced in 1911 when Ohm gave an injection of air into the vitreous humor to repair a detached retina. In the mid-1940s, intravitreal injections became a standard way to administer drugs to treat endophthalmitis and cytomegalovirus retinitis.

<span class="mw-page-title-main">Optic disc drusen</span> Medical condition

Optic disc drusen (ODD) are globules of mucoproteins and mucopolysaccharides that progressively calcify in the optic disc. They are thought to be the remnants of the axonal transport system of degenerated retinal ganglion cells. ODD have also been referred to as congenitally elevated or anomalous discs, pseudopapilledema, pseudoneuritis, buried disc drusen, and disc hyaline bodies.

<span class="mw-page-title-main">Intermediate uveitis</span> Medical condition

Intermediate uveitis is a form of uveitis localized to the vitreous and peripheral retina. Primary sites of inflammation include the vitreous of which other such entities as pars planitis, posterior cyclitis, and hyalitis are encompassed. Intermediate uveitis may either be an isolated eye disease or associated with the development of a systemic disease such as multiple sclerosis or sarcoidosis. As such, intermediate uveitis may be the first expression of a systemic condition. Infectious causes of intermediate uveitis include Epstein–Barr virus infection, Lyme disease, HTLV-1 virus infection, cat scratch disease, and hepatitis C.

<span class="mw-page-title-main">Epiretinal membrane</span> Eye disease

Epiretinal membrane or macular pucker is a disease of the eye in response to changes in the vitreous humor or more rarely, diabetes. Sometimes, as a result of immune system response to protect the retina, cells converge in the macular area as the vitreous ages and pulls away in posterior vitreous detachment (PVD).

<span class="mw-page-title-main">Angioid streaks</span> Medical condition

Angioid streaks, also called Knapp streaks or Knapp striae, are small breaks in Bruch's membrane, an elastic tissue containing membrane of the retina that may become calcified and crack. Up to 50% of angioid streak cases are idiopathic. It may occur secondary to blunt trauma, or it may be associated with many systemic diseases. The condition is usually asymptomatic, but decrease in vision may occur due to choroidal neovascularization.

<span class="mw-page-title-main">Fuchs spot</span> Degeneration of the macula

The Fuchs spot is a degeneration of the macula in cases of high myopia. It is named after the two persons who first described it: Ernst Fuchs, who described a pigmented lesion in 1901, and Forster, who described subretinal neovascularization in 1862. It occurs due to proliferation of retinal pigment epithelium associated with choroidal hemorrhage. The size of the spots are proportionate to the severity of the pathological myopia.

Retinal gene therapy holds a promise in treating different forms of non-inherited and inherited blindness.

<span class="mw-page-title-main">Branch retinal vein occlusion</span> Medical condition

Branch retinal vein occlusion is a common retinal vascular disease of the elderly. It is caused by the occlusion of one of the branches of central retinal vein.

<span class="mw-page-title-main">Vitreomacular adhesion</span> Human medical condition

Vitreomacular adhesion (VMA) is a human medical condition where the vitreous gel of the human eye adheres to the retina in an abnormally strong manner. As the eye ages, it is common for the vitreous to separate from the retina. But if this separation is not complete, i.e. there is still an adhesion, this can create pulling forces on the retina that may result in subsequent loss or distortion of vision. The adhesion in of itself is not dangerous, but the resulting pathological vitreomacular traction (VMT) can cause severe ocular damage.

<span class="mw-page-title-main">Intravitreal injection</span> Method of administration of drugs into the eye by injection with a fine needle

Intravitreal injection is the method of administration of drugs into the eye by injection with a fine needle. The medication will be directly applied into the vitreous humor. It is used to treat various eye diseases, such as age-related macular degeneration (AMD), diabetic retinopathy, and infections inside the eye such as endophthalmitis. As compared to topical administration, this method is beneficial for a more localized delivery of medications to the targeted site, as the needle can directly pass through the anatomical eye barrier and dynamic barrier. It could also minimize adverse drug effects on other body tissues via the systemic circulation, which could be a possible risk for intravenous injection of medications. Although there are risks of infections or other complications, with suitable precautions throughout the injection process, chances for these complications could be lowered.

<span class="mw-page-title-main">Pachychoroid disorders of the macula</span>

Pachychoroid disorders of the macula represent a group of diseases affecting the central part of the retina of the eye, the macula. Due to thickening and congestion of the highly vascularized layer underneath the macula, the choroid, damage to the retinal pigment epithelium and the retinal photoreceptor cells ensues. This leads to impaired vision. The best known representative of the pachychoroid disease spectrum, central serous chorioretinopathy, is the fourth most common cause of irreversible damage to the macula:.

<span class="mw-page-title-main">Indocyanine green angiography</span> Diagnostic procedure

Indocyanine green angiography (ICGA) is a diagnostic procedure used to examine choroidal blood flow and associated pathology. Indocyanine green (ICG) is a water soluble cyanine dye which shows fluorescence in near-infrared (790–805 nm) range, with peak spectral absorption of 800-810 nm in blood. The near infrared light used in ICGA penetrates ocular pigments such as melanin and xanthophyll, as well as exudates and thin layers of sub-retinal vessels. Age-related macular degeneration is the third main cause of blindness worldwide, and it is the leading cause of blindness in industrialized countries. Indocyanine green angiography is widely used to study choroidal neovascularization in patients with exudative age-related macular degeneration. In nonexudative AMD, ICGA is used in classification of drusen and associated subretinal deposits.

Sickle cell retinopathy can be defined as retinal changes due to blood vessel damage in the eye of a person with a background of sickle cell disease. It can likely progress to loss of vision in late stages due to vitreous hemorrhage or retinal detachment. Sickle cell disease is a structural red blood cell disorder leading to consequences in multiple systems. It is characterized by chronic red blood cell destruction, vascular injury, and tissue ischemia causing damage to the brain, eyes, heart, lungs, kidneys, spleen, and musculoskeletal system.

Valsalva retinopathy is a form of retinopathy due to retinal bleeding secondary to rupture of retinal vessels caused by intrathoracic or intra-abdominal pressure due to physical activities.

Polypoidal choroidal vasculopathy (PCV) is an eye disease primarily affecting the choroid. It may cause sudden blurring of vision or a scotoma in the central field of vision. Since Indocyanine green angiography gives better imaging of choroidal structures, it is more preferred in diagnosing PCV. Treatment options of PCV include careful observation, photodynamic therapy, thermal laser, intravitreal injection of anti-VEGF therapy, or combination therapy.

References

  1. 1 2 Shukla, Unnati V.; Kaufman, Evan J. (2022), "Intraocular Hemorrhage", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   33620856 , retrieved 2022-10-28
  2. ↑ Shukla, Unnati V.; Kaufman, Evan J. (2021), "Intraocular Hemorrhage", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   33620856 , retrieved 2021-06-01
  3. ↑ Cionni, Robert J.; Snyder, Michael E.; Osher, Robert H. (2006). "6: Cataract surgery". In Tasman, William (ed.). Duane's Opthalmology. Vol. 6. Lippincott, Williams and Wilkins. Retrieved 16 February 2023– via www.oculist.net.
  4. ↑ Chaturvedi, Vivek; Sabherwal, Ryan; Kim, Leo A.; Pittner, Andrew; Bhagat, Neelakshi; Lim, Jennifer I; Mukkamala, Lekha; Patel, Nimesh (23 June 2022). Patel, Nimesh (ed.). "Suprachoroidal Hemorrhage". Eyewiki. American Academy of Opthalmology.
  5. 1 2 Jena, Soumya; Tripathy, Koushik (2021), "Vitreous Hemorrhage", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   32644557 , retrieved 2021-06-01
  6. ↑ Naik, Anmol U; Rishi, Ekta; Rishi, Pukhraj (June 2019). "Pediatric vitreous hemorrhage: A narrative review". Indian Journal of Ophthalmology. 67 (6): 732–739. doi: 10.4103/ijo.IJO_688_18 . ISSN   0301-4738. PMC   6552577 . PMID   31124481.
  7. ↑ Casini, Giamberto; Loiudice, Pasquale; Menchini, Martina; Sartini, Francesco; De Cillà, Stefano; Figus, Michele; Nardi, Marco (2019). "Traumatic submacular hemorrhage: available treatment options and synthesis of the literature". International Journal of Retina and Vitreous. 5: 48. doi: 10.1186/s40942-019-0200-0 . ISSN   2056-9920. PMC   6905055 . PMID   31890278.
  8. 1 2 Doshi, Ricky; Noohani, Tariq (2021), "Subconjunctival Hemorrhage", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   31869130 , retrieved 2021-06-01
  9. 1 2 3 4 Gragg, James; Blair, Kyle; Baker, Mari B. (2022), "Hyphema", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   29939579 , retrieved 2022-10-28
  10. 1 2 3 Goff, Mitchell J.; McDonald, H. Richard; Johnson, Robert N.; Ai, Everett; Jumper, J. Michael; Fu, Arthur D. (May 2006). "Causes and treatment of vitreous hemorrhage". Comprehensive Ophthalmology Update. 7 (3): 97–111. ISSN   1527-7313. PMID   16882398.
  11. ↑ Hochman, M. A.; Seery, C. M.; Zarbin, M. A. (November 1997). "Pathophysiology and management of subretinal hemorrhage". Survey of Ophthalmology. 42 (3): 195–213. doi:10.1016/s0039-6257(97)00089-1. ISSN   0039-6257. PMID   9406367.
  12. 1 2 3 4 5 Kanukollu, Venkata M.; Ahmad, Syed Shoeb (2022), "Retinal Hemorrhage", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID   32809612 , retrieved 2022-11-08
  13. 1 2 "Management of Submacular Hemorrhage". American Academy of Ophthalmology. 2018-02-01. Retrieved 2022-11-08.
  14. ↑ "What Is Hyphema?". American Academy of Ophthalmology. 2022-05-03. Retrieved 2022-10-31.
  15. ↑ "Subconjunctival hemorrhage (broken blood vessel in eye) - Symptoms and causes". Mayo Clinic. Retrieved 2022-10-28.
  16. ↑ Lowe, Robert J.; Rosen, Richard B.; Gentile, Ronald C. (1 June 2011). "Treatment Options for Submacular Hemorrhage". www.retinalphysician.com. Retrieved 2022-11-08.
  17. ↑ Kim, Seung-Ju; Ahn, Joonghyun; Kim, Hyung Kook; Kim, Jong Hun (2016-02-29). "Obese children experience more extremity fractures than nonobese children and are significantly more likely to die from traumatic injuries". Acta Paediatrica. 105 (10): 1152–1157. doi:10.1111/apa.13343. ISSN   0803-5253. PMID   27634684. S2CID   35386852.
  18. ↑ G, Lindgren; L, Sjödell; B, Lindblom (Apr 1995). "A prospective study of dense spontaneous vitreous hemorrhage". American Journal of Ophthalmology. 119 (4): 458–465. doi:10.1016/s0002-9394(14)71232-2. ISSN   0002-9394. PMID   7709970.
  19. ↑ Wang, Ching-Yu; Cheang, Wai-Man; Hwang, De-Kuang; Lin, Ching-Heng (2017). "Vitreous haemorrhage: a population-based study of the incidence and risk factors in Taiwan". International Journal of Ophthalmology. 10 (3): 461–466. doi:10.18240/ijo.2017.03.21. ISSN   2222-3959. PMC   5360784 . PMID   28393040.
  20. 1 2 3 Talany, G.; Guo, M.; Etminan, M. (April 2017). "Risk of intraocular hemorrhage with new oral anticoagulants". Eye. 31 (4): 628–631. doi:10.1038/eye.2016.265. ISSN   1476-5454. PMC   5395993 . PMID   28009346. S2CID   4474979.
  21. 1 2 Budenz, Donald L.; Farber, Martha G.; Mirchandani, Haresh G.; Park, Hydow; Rorke, Lucy B. (1994-03-01). "Ocular and Optic Nerve Hemorrhages in Abused Infants with Intracranial Injuries". Ophthalmology. 101 (3): 559–565. doi: 10.1016/S0161-6420(94)31300-5 . ISSN   0161-6420. PMID   8127577.
  22. ↑ Mannino, Giuseppe; Verrilli, Sara; Calafiore, Silvia; Ciarnella, Angela; Cutini, Alessandro; Mannino, Cristina; Perdicchi, Andrea; Recupero, Santi Maria (2012-10-04). "Evaluation of recurrent hyphema after trabeculectomy with ultrabiomicroscopy 50-80 MHz: a case report". BMC Research Notes. 5: 549. doi: 10.1186/1756-0500-5-549 . ISSN   1756-0500. PMC   3514379 . PMID   23035908.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.